Articles with public access mandates - Gary HammerLearn more
Not available anywhere: 3
Adrenocortical carcinoma and succinate dehydrogenase gene mutations: an observational case series
T Else, AM Lerario, J Everett, L Haymon, D Wham, M Mullane, TLS Wilson, ...
European journal of endocrinology 177 (5), 439-444, 2017
Mandates: US National Institutes of Health, American Heart Association, Doris Duke …
Withanolides are potent novel targeted therapeutic agents against adrenocortical carcinomas
C Subramanian, H Zhang, R Gallagher, G Hammer, B Timmermann, ...
World journal of surgery 38, 1343-1352, 2014
Mandates: US National Institutes of Health
PreImplantation factor (PIF*) regulates stress-induced adrenal steroidogenesis and anti-inflammatory cytokines: potential application for bioartificial adrenal transplant
M Balyura, E Gelfgat, E Ullmann, B Ludwig, ER Barnea, SR Bornstein
Hormone and Metabolic Research 50 (02), 168-174, 2018
Mandates: German Research Foundation
Available somewhere: 71
Oncogenic signaling pathways in the cancer genome atlas
F Sanchez-Vega, M Mina, J Armenia, WK Chatila, A Luna, KC La, ...
Cell 173 (2), 321-337. e10, 2018
Mandates: US National Institutes of Health
Diagnosis and treatment of primary adrenal insufficiency: an endocrine society clinical practice guideline
SR Bornstein, B Allolio, W Arlt, A Barthel, A Don-Wauchope, GD Hammer, ...
The Journal of Clinical Endocrinology & Metabolism 101 (2), 364-389, 2016
Mandates: US National Institutes of Health, UK Medical Research Council
Adrenocortical carcinoma
T Else, AC Kim, A Sabolch, VM Raymond, A Kandathil, EM Caoili, S Jolly, ...
Endocrine reviews 35 (2), 282-326, 2014
Mandates: US National Institutes of Health
Comprehensive pan-genomic characterization of adrenocortical carcinoma
S Zheng, AD Cherniack, N Dewal, RA Moffitt, L Danilova, BA Murray, ...
Cancer cell 29 (5), 723-736, 2016
Mandates: US National Institutes of Health
Molecular classification and prognostication of adrenocortical tumors by transcriptome profiling
TJ Giordano, R Kuick, T Else, PG Gauger, M Vinco, J Bauersfeld, ...
Clinical cancer research 15 (2), 668-676, 2009
Mandates: US National Institutes of Health
Telomere protection by mammalian Pot1 requires interaction with Tpp1
D Hockemeyer, W Palm, T Else, JP Daniels, KK Takai, JZS Ye, ...
Nature structural & molecular biology 14 (8), 754-761, 2007
Mandates: German Research Foundation
Preclinical targeting of the type I insulin-like growth factor receptor in adrenocortical carcinoma
FM Barlaskar, AC Spalding, JH Heaton, R Kuick, AC Kim, DG Thomas, ...
The Journal of Clinical Endocrinology & Metabolism 94 (1), 204-212, 2009
Mandates: US National Institutes of Health
Targeted disruption of β-catenin in Sf1-expressing cells impairs development and maintenance of the adrenal cortex
AC Kim, AL Reuter, M Zubair, T Else, K Serecky, NC Bingham, GG Lavery, ...
Oxford University Press for The Company of Biologists Limited 135 (15), 2593 …, 2008
Mandates: US National Institutes of Health
Safety, tolerability, and pharmacokinetics of the anti-IGF-1R monoclonal antibody figitumumab in patients with refractory adrenocortical carcinoma
P Haluska, F Worden, D Olmos, D Yin, D Schteingart, GN Batzel, ...
Cancer chemotherapy and pharmacology 65, 765-773, 2010
Mandates: US National Institutes of Health
Epigenetic silencing of engineered L1 retrotransposition events in human embryonic carcinoma cells
JL Garcia-Perez, M Morell, JO Scheys, DA Kulpa, S Morell, CC Carter, ...
Nature 466 (7307), 769-773, 2010
Mandates: US National Institutes of Health, Howard Hughes Medical Institute
Adrenocortical carcinoma is a Lynch syndrome–associated cancer
VM Raymond, JN Everett, LV Furtado, SL Gustafson, CR Jungbluth, ...
Journal of Clinical Oncology 31 (24), 3012-3018, 2013
Mandates: US National Institutes of Health
Adjuvant therapies and patient and tumor characteristics associated with survival of adult patients with adrenocortical carcinoma
T Else, AR Williams, A Sabolch, S Jolly, BS Miller, GD Hammer
The Journal of Clinical Endocrinology & Metabolism 99 (2), 455-461, 2014
Mandates: US National Institutes of Health
Progression to adrenocortical tumorigenesis in mice and humans through insulin-like growth factor 2 and β-catenin
JH Heaton, MA Wood, AC Kim, LO Lima, FM Barlaskar, MQ Almeida, ...
The American journal of pathology 181 (3), 1017-1033, 2012
Mandates: US National Institutes of Health
Development of adrenal cortex zonation
Y Xing, AM Lerario, W Rainey, GD Hammer
Endocrinology and Metabolism Clinics 44 (2), 243-274, 2015
Mandates: US National Institutes of Health
In search of adrenocortical stem and progenitor cells
AC Kim, FM Barlaskar, JH Heaton, T Else, VR Kelly, KT Krill, JO Scheys, ...
Endocrine reviews 30 (3), 241-263, 2009
Mandates: US National Institutes of Health
Dax-1 and steroid receptor RNA activator (SRA) function as transcriptional coactivators for steroidogenic factor 1 in steroidogenesis
B Xu, WH Yang, I Gerin, CD Hu, GD Hammer, RJ Koenig
Molecular and cellular biology, 2009
Mandates: US National Institutes of Health
Genetics and epigenetics of adrenocortical tumors
AM Lerario, A Moraitis, GD Hammer
Molecular and cellular endocrinology 386 (1-2), 67-84, 2014
Mandates: US National Institutes of Health
Publication and funding information is determined automatically by a computer program